BMS - Autoimmune Disease Drugs Business Funding

BMS - Autoimmune Disease Drugs Business is based in New York City. It has raised $300M in total funding. Latest round: Series A.

BMS - Autoimmune Disease Drugs Business funding overview

BMS - Autoimmune Disease Drugs Business is based in New York City. BMS - Autoimmune Disease Drugs Business has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in July 2025. The round record for BMS - Autoimmune Disease Drugs Business runs through 2025; nothing later has been disclosed. Investors on record include Bain Capital, Bain Capital Life Sciences. 2 distinct backers are named across the disclosed rounds.

BMS - Autoimmune Disease Drugs Business at a glance

Total raised
$300M
Latest round
Series A
Latest round date
July 2025
Headquarters
New York City
Notable investors
Bain Capital, Bain Capital Life Sciences

Frequently asked about BMS - Autoimmune Disease Drugs Business funding

How much has BMS - Autoimmune Disease Drugs Business raised?
BMS - Autoimmune Disease Drugs Business has raised $300M in total disclosed funding across the rounds on record.
Who has invested in BMS - Autoimmune Disease Drugs Business?
Bain Capital, Bain Capital Life Sciences are named among the investors backing BMS - Autoimmune Disease Drugs Business.
What was the latest BMS - Autoimmune Disease Drugs Business funding round?
The most recent disclosed round is a Series A, announced in July 2025.
Where is BMS - Autoimmune Disease Drugs Business based?
BMS - Autoimmune Disease Drugs Business is based in New York City.
When did BMS - Autoimmune Disease Drugs Business last raise?
The last disclosed BMS - Autoimmune Disease Drugs Business round closed in July 2025 at Series A.

Round data for BMS - Autoimmune Disease Drugs Business is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.

Companies related to BMS - Autoimmune Disease Drugs Business (36)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades